Home  -  Type 1 Diabetes  -  Autoimmune Liver Disease  -  Teaching/Vorlesungen
 Publications  -  Collaborations  -  Group Members - Contact 



Collaborations

 



Matthias G. von Herrath, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA

- RIP-LCMV model for Type 1 Diabetes
- CYP2D6 mouse model for autoimmune liver disease



Michael P. Manns, Medizinische Hochschule Hannover, Hannover, Germany

- CYP2D6 mouse model for autoimmune liver disease
- Epitope spreading in patients with autoimmune hepatitis



Andrew D. Luster, Massachusetts General Hospital, Harvard Medical School, Charlestown MA, USA

- Role of CXCL10 / IP-10 in Type 1 Diabetes



Frank J. Gonzalez, National Cancer Institute, National Institute of Health, Bethesda MD, USA

- CYP2D6 mouse model for autoimmune liver disease



Heinfried H. Radeke, Pharmazentrum Frankfurt, Frankfurt, Germany

- Vitamin D therapy of Type 1 Diabetes



Beat Imhof,  Geneva Faculty of Medicine, Geneva, Switzerland

- Role of JAM in cellular recruitement to the islets of Langerhans



Eric F. Johnson, The Scripps Research Institute, La Jolla, CA, USA

- CYP2D6 mouse model for autoimmune liver disease